endocrinology Flashcards
types of inuslin
rapid acting - insulin aspart- Novorapid
short acting - soluble insulin - Actrapid
intermediate acting - isophane (NPH) - Humulin 1
Long acting - insulin glargine(lantus), insulin determir (levemir)
biphasic insulin preparations - mixture of rapid and intermediate - novomix 30 (aspart + aspart protamine)
mode of action of insulin
in diabetes, stimulates glucose uptake from circulation into tissues inc. skeletal muscle and fat and increases use of glucose as energy store
stimulates glycogen, lipid and protein synthesis and inhibits gluconeogenesis amnd ketogenesis
reduces serum K+ short term
indications for insulin
insulin replacement with type 1 diabetes and for blood flucose control in type 2 hwere oral hypoglycaemic treatment is inadequate
IV for diabetic emergencies (ketoacidosis, hyperglycaemias hyperosmolar synfrome and for perioperative glycaemic control)
hyperkalaemia - alongisde glucose while other measures initiated
contraindications for insulin
renal impairment
insulin clearance reduced = icnreased risk of hypoglycaemia
side effects of insulin
hypoglycaemia - severe can lead to coma and death
repeated SC injection at same site = fat overgrwoth (lipohypertrophy)
interactions of insulin
other hypoglycaemic agents increase risk of hypoglycaemia
concurrent therapy with systemic corticosteroids increase insulin requirements
gliclazide
sulphonylureas
gliclazide/sulphonylureas mode of action
lower blood glucose by stimulating pancreatic inuslin secretion
indications for sulphonylureas
type 2 DM
contorl blood glucose and reduce complications where metformin is contraindicated
in combo with metofrmin where blood glucose inadequately controlled
contra-indications of sulphonylureas
hepatic impairemnt - reduced dose
gluocse monitoring in renal impairment
side effects of sulphonylureas
dose related side effects such as GI upset
hypoglucaemia in high doses, or reduced drug metabolims or when in combo with other hypoglycaemics
hypersenstivity reactions are rare but cause hepatic toxicity, drug hypersensitivity syndrome and haematological abnromalities
interactions of sulphonylureas
increased risk of hypoglycaemia if prescribed with metformin, thiazolidinediones and insulin
efficacy reduced by drugs that elevate blood glucose - prenisolone, thiazide and loop diuretics
metformin
biguanides
mode of action of metformin/biguanides?
lowers blood glucose by increasing repsonse to insulin
does not stimulate pancreatic insulin so does not cuasse hypoglycaemia
reduces weight gain and induce wieght loss = prevent worsening of insulin resistance and deterioration of DM
indications of metformin/biguanides?
type 2 DM as first choice medication for control of blood glucose, used alone in combination with other hypoglycaemic drugs (sulphonylureas) or insulin
contraindications of metformin/biguanides
severe renal impairement
withheld in AKI, acute alcohol intoxication and chronic alcohol intoxication
caution in hepatic impairment
side effects of metformin/biguanides
GI upset
lactic acidosis - rare but fatal if untreated
interactions of metformin/biguanides
witheld 48hr post injection of IV contrast - increased risk of renal impairment, metformin acuclulation and lactic acidosis
other drugs impairing renal function
prednisolone thiazide, loop diuretics, elevate blood glucose and reduce efficacy